The European Brain Involvement in Dystrophinopathies (BIND) consortium (https://bindproject.eu/,accessed on 6 February 2023) aims to investigate and characterize further the role of the various dystrophin isoforms in the CNS and evaluate the potential reversibility of the central deficits associated with the lack of dystrophin. The gene discussed is DMD; the disease is neuromuscular disease caused by qualitative or quantitative defects of dystrophin.